STOCK-BASED COMPENSATION (Tables)

9 Months Ended

Sep. 30, 2014

Stock-Based Compensation Cost and Associated Tax Benefit

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2014		2013		2014		2013
Stock-based compensation cost	$	19.3	$	16.0	$	59.9	$	49.3
Tax benefit	$	6.2	$	5.9	$	19.0	$	17.9

Weighted Average Assumptions used in Determining Fair Value for Options Granted

Expected dividend yield	1.41%
Expected stock volatility	41.2%
Risk-free interest rate	2.30%
Expected holding period	7.2 years
Grant date fair value	$ 31.53

Stock Option Exercises and Restricted Stock Vesting

	Nine Months Ended
	September 30,
Exercise of stock options:	2014		2013
Proceeds from stock option exercises	$	131.5	$	124.4
Aggregate intrinsic value	$	107.7	$	89.0
Tax benefit realized upon exercise	$	38.7	$	32.6
Number of shares exercised		2.8		3.5

	Nine Months Ended
	September 30,
Vesting of restricted stock:	2014		2013
Fair value of shares vested	$	92.3	$	54.0
Tax benefit realized upon vesting	$	31.6	$	19.2
Number of shares vested		1.2		1.1

	Nine Months Ended
	September 30,
Vesting of performance-based restricted stock:	2014		2013
Fair value of shares vested	$	38.0	$	25.5
Tax benefit realized upon vesting	$	14.6	$	9.7
Number of shares vested		0.5		0.5

- Definition

Tabular disclosure of components of a stock option or other award plan under which equity-based compensation is awarded to employees, typically comprised of the amount of unearned compensation (deferred compensation cost), compensation expense, and changes in the quantity and fair value of the shares (or other type of equity) granted, exercised, forfeited, and issued and outstanding pertaining to that plan. Disclosure may also include nature and general terms of such arrangements that existed during the period and potential effects of those arrangements on shareholders, effect of compensation cost arising from equity-based payment arrangements on the income statement, method of estimating the fair value of the goods or services received, or the fair value of the equity instruments granted, during the period, cash flow effects resulting from equity-based payment arrangements and, for registrants that accelerate vesting of out of the money share options, reasons for the decision to accelerate.

+ References+ Details